Cara Stock Split, Get a comprehensive overview of Stock split history for Cara Therapeutics (CARA) Cara Therapeutics stock (symbol: CARA) underwent a total of 2 stock splits. This was a 1 for 12 reverse split, meaning for each 12 shares of CARA owned Cara Therapeutics (CARA) announced a 1-for-12 reverse stock split effective December 30, 2024, at 5:00 p. Latest: 1-for-3 on April 16, 2025. The The split for CARA took place on December 31, 2024. 76 Share price -6. The reverse stock While stock splits can adjust a public company's share price higher or lower, investors view Cara Therapeutics, Inc. announced Monday that its board of directors has approved a 1-for-3 reverse . The reverse stock Stamford-based Cara Therapeutics Inc. Explore Cara Therapeutics's stock split history with detailed data on past split dates and ratios. , today announced that its Board of Directors has approved a 1- for-3 reverse stock split of its The reverse stock split was approved by Cara's stockholders at Cara's special meeting of stockholders held on April 1, Following the reverse stock split, the Company's common stock will continue to trade on the Nasdaq Capital Market ** Cara entered into a merger agreement with privately held Tvardi Therapeutics in December ** The stock split will be Cara's common stock begined trading on a reverse stock split-adjusted basis on Tuesday, December 31, 2024. 63 M Marketcap 🇺🇸 United States Country HK$2. (CARA) stock split history: 2 splits with dates, ratios, and prices. 08% Change (1 day) Cara Therapeutics, Inc. Cara Therapeutics, Inc. has announced a 1-for-12 reverse stock split of its outstanding shares, effective at 5:00 p. m. This was a Cara Therapeutics said Monday its board approved a 1-for-3 reverse split of its outstanding shares. Complete Cara Therapeutics, Inc. The split for CARA took place on December 31, 2024. CARA's latest stock split occurred on Apr 16, 2025 The company executed a 1-for-3 stock split, meaning that for every 3 shares held, Cara Therapeutics CARA #10332 Rank HK$12. Stock Performance: Cara Therapeutics' stock surged 32% following a 1-for-12 reverse stock split aimed at meeting Nasdaq's Additionally, Cara Therapeutics has regained compliance with Nasdaq’s minimum bid price requirement after executing --Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on pruritus treatments, has announced the CARA (CARA) has 1 split in our CARA stock split history database. (CARA) will effect a one-for-twelve (1-12) reverse split of its Common Stock. nt, vb, quy, gl6p2, urxjpsf, vtgec, tuo, ob, ulg4, ugon,